l General Information |
Product Name | Lixisenatide |
General description | Lixisenatide is a once-daily short-acting glucagon-like peptide-1 (GLP-1) receptor agonist (GLP-1RA) with an IC50 of 1.4 nM for the human GLP-1 receptor in receptor binding studies. |
Synonym | Lyxumia, Adlyxin, ZP10A peptide, AVE0010 |
Purity | ≥98.5%(HPLC) | CAS Number | 320367-13-3 |
Formula | C215H347N61O65S | Molecular Weight | 4858.49 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Solid |
Solubility(25°C) | Water | ≥50mg/mL |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
